Boston Scientific Snags FDA Approval for Ablation Catheters

The FDA has approved Boston Scientific’s IntellaNav XP and MiFi XP navigation-enabled ablation catheters for the treatment of Type I atrial flutter, the device giant announced Tuesday.

Both devices contain sensors which are able to magnetically track the location of the catheter.

In addition, the catheters can be used in conjunction with the company’s Rhythmia Mapping system — which can produce three-dimensional images of any heart chamber — to improve cardiac ablation procedures and to diagnose arrhythmias, according to the company. — Anisa Jibrell